A dose effect of IL-7 on thymocyte development

Blood

Volumn 104, Issue 5, 2004, Pages 1419-1427

  El Kassar, Nahed ^b   Lucas, Philip J ^b   Klug, David B ^b   Zamisch, Monica ^b   Merchant, Melinda ^b   Bare, Catherine V ^b   Choudhury, Baishakhi ^b   Sharrow, Susan O ^b   Richie, Ellen ^b   Mackall, Crystal L ^b   Gress, Ronald E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 7; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; DOSE RESPONSE; GENE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERLEUKIN 7 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE; PROMOTER REGION; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE;

EID: 4444284575     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0201     Document Type: Article

References (55)

1. von Freeden-Jeffry U, Solvason N, Howard M, Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity. 1997;7:147-154.
2. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin IL-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 1995;181:1519-1526.
3. Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med. 1994;180:1955-1960.
4. Maki K, Sunaga S, Komagata Y, et al. Interleukin 7 receptor-deficient mice lack gamma delta T cells. Proc Natl Acad Sci U S A. 1996;93:7172-7177.
5. Cao XQ, Shores EW, Huli J, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor-gamma chain. Immunity. 1995;2:223-238.
6. Di Santo JP, Muller W, Guygrand D, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin-2 receptor-gamma chain. Proc Natl Acad Sci U S A. 1995;92:377-381.
7. Ohbo K, Suda T, Hashiyama M, et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood. 1996;87:956-967.
8. Nosaka T, Vandeursen JMA, Tripp RA, et al. Defective lymphoid development in mice lacking Jak3. Science. 1995;270:800-802.
9. Park SY, Saijo K, Takahashi T, et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 1995;3:771-782.
10. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. Defects in B-lymphocyte maturation and T-lymphocyte activation in mice lacking Jak3. Science. 1995;270:794-797.
11. Rodig SJ, Meraz MA, White JM, et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the jaks in cytokine-induced biologic responses. Cell. 1998;93:373-383.
12. Candeias S, Muegge K, Durum SK. IL-7 receptor and VDJ recombination: trophic versus mechanistic actions. Immunity. 1997;6:501-508.
13. Durum SK, Candelas S, Nakajima H, et al. Interleukin-7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. J Exp Med. 1998;188:2233-2241.
14. Moore TA, vonFreeden-Jeffry U, Murray R, Zlotnik A. Inhibition of gamma-delta T-cell development and early thymocyte maturation in IL-7-/-mice. J Immunol. 1996;157:2366-2373.
15. Kang J, Coles M, Raulet DH. Defective development of gamma/delta T cells in interleukin-7 receptor-deficient mice is due to impaired expression of T-cell receptor gamma genes. J Exp Med. 1999;190:973-982.
16. Suda T, Zlotnik A. IL-7 maintains the T-cell precursor potential of CD3-CD4-CD8- thymocytes. J Immunol. 1991;146:3068-3073.
17. +/- precursor cells and blocks the differentiation pathway of TCR-alpha-beta cells in fetal thymus organ culture. J Immunol. 1993;150:2706-2716.
18. Moore TA, Zlotnik A. T-cell lineage commitment and cytokine responses of thymic progenitors. Blood. 1995;86:1850-1860.
19. Varas A, Vicente A, Jimenez E, et al. Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-alpha beta cells selectively to the CD8+ cell lineage. Immunology. 1997;92:457-464.
20. Samaridis J, Casorati G, Traunecker A, et al. Development of lymphocytes in interleukin-7 transgenic mice. Eur J Immunol. 1991;21:453-460.
21. Rich BE, Campostorres J, Tepper RI, Moreadith RW, Leder P. Cutaneous lymphoproliferation and lymphomas in interleukin-7 transgenic mice. J Exp Med. 1993;177:305-316.
22. Mertsching E, Grawunder U, Meyer V, Rolink T, Ceredig R. Phenotypic and functional analysis of B lymphopoiesis in interleukin-7-transgenic mice: expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen. Eur J Immunol. 1996;26:28-33.
23. Williams IR, Rawson EA, Manning L, Karaoli T, Rich BE, Kupper TS. IL-7 overexpression in transgenic mouse keratinocytes causes a lymphoproliferative skin disease dominated by intermediate TCR cells: evidence for a hierarchy in IL-7 responsiveness among cutaneous T-cells. J Immunol. 1997;159:3044-3056.
24. Shimizu C, Kawamoto H, Yamashita M, et al. Progression of T-cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. Intl Immunol. 2001;13:105-117.
25. Buckland J, Pennington DJ, Bruno L, Owen MJ. Co-ordination of the expression of the protein tyrosine kinase p56(lck) with the pre-T-cell receptor during thymocyte development. Eur J Immunol. 2000;30:8-18.
26. Allen JM, Forbush KA, Perlmutter RM. Functional dissection of the lck proximal prometer. Mol Cell Biol. 1992;12:2758-2768.
27. Faust C, Schumacher A, Holdener B, Magnuson T. The Eed mutation disrupts anterior mesoderm production in mice. Development. 1995;121:273-285.
28. Sudo T, Nishikawa S, Ohno N, et al. Expression and function of the interleukin-7 receptor in murine lymphocytes. Proc Natl Acad Sci U S A. 1993;90:9125-9129.
29. Nakamura H, Gress RE. Interleukin-2 enhancement of veto suppressor cell function in T-cell-depleted bone marrow in vitro and in vivo. Transplantation. 1990;49:931-937.
30. Grabstein KH, Waldschmidt TJ, Finkelman FD, et al. Inhibition of murine B-lymphopoiesis and T-lymphopoiesis in vivo by an anti-interleukin-7 monoclonal antibody. J Exp Med. 1993;178:257-264.
31. Sakata T, Iwagami S, Tsuruta Y, et al. Constitutive expression of interleukin-7 messenger-RNA and production of IL-7 by a cloned murine thymic stromal cell line. J Leuk Biol. 1990;48:205-212.
32. Namen AE, Lupton S, Hjerrild K, et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature. 1988;333:571-573.
33. Guidos CJ, Danska JS, Fathman CG, Weissman IL. T-cell receptor-mediated negative selection of autoreactive lymphocyte T-precursors occurs after commitment to the CD4 or CD8 lineages. J Exp Med. 1990;172:835-845.
34. von Boehmer H. Positive selection of lymphocytes. Cell. 1994;76:219-228.
35. Shortman K, Vremec D, Egerton M. The kinetics of T-cell antigen receptor expression by subgroups of CD4+8+ thymocytes: delineation of CD4+8+3(2+) thymocytes as post-selection intermediates leading to mature T-cells. J Exp Med. 1991;173:323-332.
36. Akashi K, Weissman IL. The c-kit(+) maturation pathway in mouse thymic T-cell development: lineages and selection. Immunity. 1996;5:147-161.
37. Swat W, Dessing M, Vonboehmer H, Kisielow P. CD69 expression during selection and maturation of CD4+8+ thymocytes. Eur J Immunol. 1993;23:739-746.
38. Yamashita I, Nagata T, Tada T, Nakayama T. CD69 cell-surface expression identifies developing thymocytes which audition for T-cell antigen receptor-mediated positive selection. Intl Immunol. 1993;5:1139-1150.
39. Akashi K, Kondo M, von Freeden-Jeffrey U, Murray R, Weissman IL. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 1997;89:1033-1041.
40. Linette GP, Grusby MJ, Hedrick SM, Hansen TH, Glimcher LH, Korsmeyer SJ. Bcl-2 is up-regulated at the CD4+CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity. 1994;1:197-205.
41. Pearse M, Wu L, Egerton M, Wilson A, Shortman K, Scollay R. A murine early thymocyte developmental sequence is marked by transient expression of the interleukin-2 receptor. Proc Natl Acad Sci U S A. 1989;86:1614-1618.
42. Godfrey DI, Kennedy J, Suda T, Zlotnik A. A developmental pathway involving 4 phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult-mouse thymocytesdefined by CD44 and CD25 expression. J Immunol. 1993;150:4244-4252.
43. Ardavin C, Wu L, Li CL, Shortman K. Thymic dendritic cells and T-cells develop simultaneously in the thymus from a common precursor population. Nature. 1993;362:761-763.
44. Matsuzaki Y, Gyotoku J, Ogawa M, et al. Characterization of c-kit positive intrathymic stem-cells that are restricted to lymphoid differentiation. J Exp Med. 1993;178:1283-1292.
45. Godfrey DI, Kennedy J, Mombaerts P, Tonegawa S, Zlotnik A. Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. J Immunol. 1994;152:4783-4792.
46. Wu L, Li CL, Shortman K. Thymic dendritic cell precursors: relationship to the T-lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med. 1996;184:903-911.
47. Fehling HJ, Krotkova A, Saintruf C, von Boemer H. Crucial role of the pre-T-cell receptor-alpha gene in development of alpha-beta but not gamma-delta T-cells. Nature. 1995;375:795-798.
48. Maraskovsky E, Oreilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A. Bcl-2 can rescue T-lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1(-/-) mice. Cell. 1997;89:1011-1019.
49. O'Reilly LA, Harris AW, Strasser A. Bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8-T cell progenitors. Intl Immunol. 1997;9:1291-1301.
50. Endl E, Gerdes J. The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res. 2000;257:231-237.
51. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone-marrow. J Exp Med. 1991;173:1213-1225.
52. Miller JP, Izon D, DeMuth W, Gerstein R, Bhandoola A, Allman D. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin-7. J Exp Med. 2002;196:705-711.
53. Brugnera E, Bhandoola A, Cibotti R, et al. Coreceptor reversal in the thymus: signaled CD4(+) 8(+) thymocytes initially terminate CD8 transcription even when differentiating into CD8(+) T cells. Immunity. 2000;13:59-71.
54. Ruiz-Mateos E, de la Rosa R, Franco JM, et al. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy. AIDS. 2003;17:947-954.
55. Fry TJ, Mackall CL. Interleukin-7 and immunorestoration in HIV: beyond the thymus. J Hematother Stem Cell Res. 2002;11:803-807.